MedTrace Logo

AMR-DetecTool for the Diagnostic of MDR Bacterial Infections

NCT05378217 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 167

Last updated 2023-02-06

No results posted yet for this study

Summary

The fight against bacteria is one of the greatest challenges faced by societies, especially with the spread of multi drug resistant (MDR) bacteria. The failure to stop the spread of antimicrobial resistance (AMR) is due to a lack of fast detection methods and proper strategies.

Novel, rapid and reliable detection and characterization tests are an urgent need for differentiating between bacterial and viral infections and identifying AMR, so that the most appropriate treatment can be given in a timely manner.

AMR-DetecTool or NG Detectool is a detection system for the direct detection of AMR in clinical samples. The clinical sample is directly processed and a result indicating if the bacteria are resistant to the most relevant antibiotics is immediately shown.

It allows for a dramatic reduction in the treatment decision time upon sample reception from 24 hours (current workflow) to 15-30 minutes.

Conditions

  • Bacterial Sensitivity Tests
  • Antimicrobial Drug Resistance

Interventions

DIAGNOSTIC_TEST

AMR LFIA Assay

AMR LFIA will be performed in parallel to routine testing on appropriate sample types retrieved from routine testing : Blood, urine, BronchoAlveolar Lavage (BAL), Tracheal Aspirate (TA), Rectal swab

Sponsors & Collaborators

  • EIT Health

    collaborator OTHER

  • NG Biotech

    collaborator UNKNOWN

  • Commissariat A L'energie Atomique

    collaborator OTHER_GOV

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Thierry NAAS, Dr · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-18
Primary Completion
2022-12-20
Completion
2023-01-12

Countries

  • France
  • Hungary
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05378217 on ClinicalTrials.gov